It was a casual scroll through a niche online platform that led me to a piece of writing that has since refused to leave my mind. The author was identified only as a military man who has witnessed the horrors of insurgency first hand. The scene he described was visceral- two lifeless bodies of terrorists on the ground, a grim tableau of a never ending war. But it was the first paragraph that truly arrested me, it reframed my entire understanding of the ongoing war against insurgency in Nigeria: “When we finish with the terrorists, their sponsors, and sympathisers, there is another enemy we cannot ignore – the pharmaceutical companies quietly fueling this war.”
This single line, from a voice on the front lines, introduced a new and terrifying dimension to the fight for national security. The paragraphs that followed did not just unsettle me; they laid out a convincing case that the engine of insurgency is being silently powered by an industry we rely on for our health. This is not a peripheral issue; it is, as the soldier-writer claimed, a central front in the conflict, and it demands our immediate and undivided attention.
For years, the national conversation on banditry and insurgency has rightly focused on the terrorists, their financiers, and their ideological enablers. Our troops have tracked their weapons and we have condemned their atrocities. But the military man’s writing points to a more insidious actor, one operating with a veneer of legitimacy: the multinational pharmaceutical industry. The central thesis of his piece, which this article will expand upon, is that these companies are indirectly, and sometimes directly, supplying the chemical courage that makes our enemies so resilient and terrifying.
The evidence for this claim is no longer speculative; it is piling up on the front lines. The disturbing discoveries made by our security forces during raids on terrorist camps have become tragically routine. Alongside the expected caches of weapons and ammunition, patrols now consistently report seizing large quantities of pharmaceutical products. These are not mere medical supplies for treating the wounded, they are potent psychoactive substances: high-dose Tramadol, Diazepam, codeine based cough syrups, and even erectile dysfunction pills like Viagra.
Far from a random collection of illicit goods, this is a deliberately curated pharmacological toolkit. Its components serve specific combat roles: Tramadol and codeine act as potent painkillers and disinhibitors, allowing combatants to endure severe injury and suppressing the instinctual fear that would normally hinder their actions.
Diazepam calms nerves, creating a cold, detached, and more predictable combatant. The presence of Viagra is perhaps the most dreadful, widely understood by intelligence agencies as a tool for the systematic sexual violence used as a weapon of war to terrorise and subjugate entire communities.
This brings us back to the soldier’s damning question and the core of this investigation: How do these tightly controlled substances, manufactured by legitimate, often multinational corporations, find their way into the hands of bandits in remote forests?
The supply chain again exposes a catastrophic failure of regulation and points to a disturbing level of corporate negligence, if not outright complicity. The journey begins with a manufacturer that produces or packages these drugs. From there, they enter a distribution network riddled with loopholes. Complicit or negligent wholesalers may sell to phantom pharmacies, while corrupt officials at ports and borders allow diverted shipments to pass without checks. The National Agency for Food and Drug Administration and Control (NAFDAC) and other regulatory bodies appear either outgunned, under resourced, or compromised from within.
For the pharmaceutical companies involved, this is likely seen as a matter of profit and loss, a case of products disappearing into a complex market. But from the perspective of national security, this is tantamount to arming the enemy. Every carton of 225mg Tramadol that reaches a terrorist camp is a force multiplier as significant as a new batch of ammunition. It creates a fighter who is more reckless, more resilient, and more terrifying. It is a silent, chemical pillar propping up the very violence that is tearing our nation apart.
This crisis, brought to light by those fighting our battles, demands a response as robust and multifaceted as the threat itself. The government must immediately initiate a high priority, transparent investigation to trace seized drugs back to their source. This means identifying the specific manufacturing batch, the distributor, and every hand it passed through. The findings must be made public, and the consequences must be severe—including massive fines, the revocation of operating licenses, and criminal prosecution for corporate officials under terrorism financing laws.
Furthermore, NAFDAC requires an urgent overhaul and must be empowered with better technology and funding to implement a foolproof track-and-trace system for all controlled medicines. This is not merely a Nigerian problem; it is a regional crisis. Nigeria must lead a coalition of West African nations to blacklist and sanction pharmaceutical companies found to be wilfully blind to the diversion of their products.
We cannot hope to win this war by only fighting the symptoms we can see on the battlefield. Victory will only come when we sever every logistical and supply line that sustains the enemy. The soldier who wrote those words was right: we must confront the uncomfortable truth that corporate greed, hidden behind a veil of legitimacy, is helping to fuel the violence. Until we hold the boardrooms as accountable as the bomb-makers, the fight for peace and security will remain an uphill battle. The nation must wake up to this pharmacological front; our stability depends on it.
Discussion about this post